Leukemia, Lymphoblastic, Chronic
1 clinical trials · Condition
◉ Watch Leukemia, Lymphoblastic, Chronic
| Record | Firm | Date |
|---|---|---|
| Ofatumumab & Ibrutinib + Allogeneic Bone Marrow Transplant or Consolidation in High Risk Chronic Lymphocytic Leukemia (NCT02388048) | Gruppo Italiano Malattie EMatologiche dell'Adulto | 2015-10-01 |
Track Leukemia, Lymphoblastic, Chronic automatically
Every clearance here is in the API, with alerts when new ones post.